Serum α‐fetoprotein level at treatment completion is a useful predictor of hepatocellular carcinoma occurrence more than one year after hepatitis C virus eradication by direct‐acting antiviral treatment-Reference-Cited by-同舟云学术

Serum α‐fetoprotein level at treatment completion is a useful predictor of hepatocellular carcinoma occurrence more than one year after hepatitis C virus eradication by direct‐acting antiviral treatment

Published:2021-10-27 Issue:1 Volume:29 Page:35-42
ISSN:1352-0504
Container-title:Journal of Viral Hepatitis
language:en
Short-container-title:Journal of Viral Hepatitis

Author:

Kuwano Akifumi¹²,Yada Masayoshi¹,Nagasawa Shigehiro¹,Tanaka Kosuke¹,Morita Yusuke¹,Masumoto Akihide¹,Motomura Kenta¹

Affiliation:

1. Department of Hepatology Aso Iizuka Hospital Iizuka Fukuoka Japan

2. Department of Medicine and Bioregulatory Science Graduate School of Medical Sciences Kyushu University Higashi‐ku Fukuoka Japan

Publisher

Wiley

Subject

Virology,Infectious Diseases,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jvh.13625

Reference38 articles.

1. Hepatitis C‐global prevalence (update);World Health Organization;Wkly Epidemiol Rec,1999

2. Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance☆

3. Alcohol and Hepatocellular Carcinoma: The Effect of Lifetime Intake and Hepatitis Virus Infections in Men and Women

4. Hepatocellular Carcinoma

5. Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. FIB‑4 index and serum α‑fetoprotein are useful predictors of hepatocellular carcinoma occurrence in hepatitis B patients with nucleos(t)ide analogs therapy;Experimental and Therapeutic Medicine;2023-08-01

2. Risk factors for loss to follow‐up after the start of direct‐acting antiviral treatment for hepatitis C virus infection;JGH Open;2022-12-30

3. Direct-acting antivirals for hepatitis C virus-infected patients with hepatocellular carcinoma;World Journal of Hepatology;2022-06-27

4. The Roles and Pathogenesis Mechanisms of a Number of Micronutrients in the Prevention and/or Treatment of Chronic Hepatitis, COVID-19 and Type-2 Diabetes Mellitus;Nutrients;2022-06-24

5. Usefulness of Imaging and Biological Tools for the Characterization of Portal Vein Thrombosis in Hepatocellular Carcinoma;Diagnostics;2022-05-05